KYGEVVI

{
  "unii": {
    "unii": "0W860991D6",
    "rxcui": null,
    "inchikey": "CKTSBUTUHBMZGZ-SHYZEUOFSA-N",
    "display_name": "DOXECITINE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "spl_meta": {
    "7d5ce670-9314-4fd7-8b0a-1447910dcf9e": {
      "match": "brand_token",
      "title": "KYGEVVI (DOXECITINE AND DOXRIBTIMINE) POWDER, FOR SOLUTION [UCB, INC.]",
      "spl_version": "3",
      "published_date": "2026-03-02"
    }
  },
  "productid": "50474-350_433f8057-35f8-f7e8-e063-6294a90a3ffd",
  "productndc": "50474-350",
  "dosage_form": "POWDER, FOR SOLUTION",
  "orange_book": {
    "appl_no": "219792",
    "products": [
      {
        "rs": true,
        "rld": true,
        "te_code": null,
        "strength": "2GM/PACKET;2GM/PACKET",
        "product_no": "001",
        "approval_date": "Nov 3, 2025"
      }
    ],
    "appl_type": "N"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "DOXECITINE; DOXRIBTIMINE",
  "proprietary_name": "KYGEVVI",
  "active_ingred_unit": "g/1; g/1",
  "application_number": "NDA219792",
  "marketing_category": "NDA",
  "nonproprietary_name": "doxecitine and doxribtimine",
  "start_marketing_date": "20260301",
  "active_numerator_strength": "2; 2"
}